Prostate biopsy in selecting candidates for hemiablative focal therapy.

Published

Journal Article

Focal therapy (FT) for the management of clinically localized prostate cancer (PCa) is growing from a concept to reality because of increased interest of both patients and physicians. Selection protocols, however, are yet to be established. We discuss the role of prostate biopsy in candidate selection for FT and highlight the different strategies and technical aspects of the use of prostate biopsy in this setting. In our opinion, prostate biopsy plays a major role in the selection process and tailoring appropriate treatment strategy to the patient. FT necessitates dedicated biopsy schemes that would reliably predict the extent, nature, and location of PCa in selected patients. Currently, there is insufficient scientific evidence to propose a specific biopsy scheme that could fit every candidate, providing accurate characterization of the disease in the individual patient. Further research is necessary to establish solid selection protocols that would reliably identify appropriate candidates for FT of PCa.

Full Text

Duke Authors

Cited Authors

  • Tsivian, M; Hruza, M; Mouraviev, V; Rassweiler, J; Polascik, TJ

Published Date

  • May 2010

Published In

Volume / Issue

  • 24 / 5

Start / End Page

  • 849 - 853

PubMed ID

  • 20370327

Pubmed Central ID

  • 20370327

Electronic International Standard Serial Number (EISSN)

  • 1557-900X

Digital Object Identifier (DOI)

  • 10.1089/end.2009.0473

Language

  • eng

Conference Location

  • United States